UTI-lizer

About:

UTI-lizer develops diagnostic tests for urinary tract infections.

Website: https://www.utilizer.se

Top Investors: Almi Invest, Sting, Propel Capital

Description:

UTI-lizer is a non-optimal treatment and unnecessary use of antibiotics. They detect bacteria in the clinically relevant range, without any complicated lab instruments. They provide biotechnology research. The contact modes are by mail, phone, and physical address.

Total Funding Amount:

7M SEK

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Stockholm, Stockholms Lan, Sweden

Founded Date:

2021-01-01

Founders:

Emre Iseri, Sofia Bertling

Number of Employees:

1-10

Last Funding Date:

2023-05-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai